|
Market Closed -
OTC Markets
22:36:46 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0287 USD | -0.69% |
|
-10.31% | +10.38% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Chart calendar Adaptimmune Therapeutics plc
Upcoming events on Adaptimmune Therapeutics plc
No events available
Past events on Adaptimmune Therapeutics plc
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,3 86,1 -29.95% | 178 183 -2.71% |
|
EBITDA Million USD | Released Forecast Spread | -130 -81,7 -59% | -57,9 -33,9 -70.93% |
|
EBIT Million USD | Released Forecast Spread | -140 -105 -33.04% | -58,4 -44,8 -30.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -113 -74,3 -51.53% | -67,2 -44,7 -50.47% |
|
Net income Million USD | Released Forecast Spread | -114 -83,2 -36.95% | -70,8 -41,8 -69.21% |
|
EPS USD | Released Forecast Spread | -0,54 -0,33 -63.64% | -0,30 -0,12 -141.94% |
| Announcement Date | 06/03/24 | 24/03/25 |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 128 44,8 186.47% | 40,9 20,5 99.63% | 3,22 8,18 -60.62% | 7,29 6,55 11.2% | 13,7 8,96 52.6% |
|
EBIT Million USD | Released Forecast Spread | 68,7 -3,79 1910.46% | -14,7 -37,1 60.47% | -63,1 -49,5 -27.4% | -45,7 -49,6 7.85% | -30,3 -37,4 19.08% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 70,0 -2,93 2493.34% | -16,8 -36,5 54.04% | -72,5 -49,7 -45.94% | -47,0 -49,8 5.53% | -29,7 -38,1 21.93% |
|
Net income Million USD | Released Forecast Spread | 69,5 -7,71 1001.32% | -17,6 -35,4 50.19% | -74,2 -45,2 -64.01% | -47,6 -45,9 -3.71% | -30,3 -36,5 16.9% |
|
EPS USD | Released Forecast Spread | 0,24 -0,03 838.46% | -0,01 -0,08 87.18% | -0,30 -0,13 -123.88% | -0,18 -0,14 -30.91% | -0,12 -0,09 -33.33% |
| Announcement Date | 12/08/24 | 13/11/24 | 24/03/25 | 13/05/25 | 13/08/25 |
| Today |  | Earnings release - Q3 2026 | 14:00 |
| Today | | Earnings presentation | 15:00 |
| Today | | Earnings presentation | 23:30 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | 11:00 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Extraordinary General Meeting | 09:00 |
| Today | | Extraordinary General Meeting | 09:30 |
| Today | | Earnings release - Q3 2026 |
Past sector events for Adaptimmune Therapeutics plc
| Today | | Board of Directors Meeting | |
| Today | | Earnings presentation | |
| Today | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Earnings presentation | 15:30 |
| 28/10/2026 | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Ex-dividend date - 0.027 CNY | 07:00 |
| 28/10/2026 | | Earnings release - Q3 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADAP.Y Stock
- Calendar Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
